Polarean Imaging (POLX)

Sector:

Health Care

Index:

FTSE AIM All-Share

 0.000p
   
  • Closing Price Chg:
      0.000p
  • 52 Week High: 0.000p
  • 52 Week Low: 0.000p
  • Currency: UK Pounds
  • Shares Issued: 1,207.03m
  • Volume: 0

Latest ShareCast News

Polarean announces new deal with Virginia hospital

By Benjamin Chiou

Date: Monday 29 Sep 2025

(Sharecast News) - Medical imaging tech group Polarean Imaging has announced a new supply agreement with the University of Virginia Health, giving shares of the AIM-listed outfit a bump on Monday.

Polarean Imaging enters promotion deal with Ascend Imaging

By Josh White

Date: Tuesday 24 Jun 2025

(Sharecast News) - Polarean Imaging announced on Tuesday that it has entered into a new commercial agreement with Ascend Imaging to support the promotion and sale of its Xenon MRI technology in selected US states, in a move aimed at accelerating market penetration and expanding access to its functional lung imaging platform.

Polarean Imaging gets go-ahead to expand Xenoview use

By Josh White

Date: Monday 02 Jun 2025

(Sharecast News) - Polarean Imaging announced on Monday that it has received approval from the US Food and Drug Administration to expand the use of its lung imaging agent Xenoview to include children aged six and older, opening access to an additional one million potential patients.

Polarean's Xenoview 3T gets new FDA clearance 21-Nov-2024 ShareCast
Polarean appoints Xenon MRI specialist as chief ... 28-Aug-2024 ShareCast
Polarean Imaging retains co-founder on consultan... 15-Aug-2024 ShareCast
Polarean shares jump on MRI system order 10-May-2024 ShareCast
Polarean gets new polariser order from Cincinnat... 03-May-2024 ShareCast
Polarean gets first de novo order for Xenoview p... 07-Dec-2023 ShareCast
Polarean Imaging enters strategic partnership wi... 08-Sep-2023 ShareCast
Polarean's Xenoview gets US reimbursement code 29-Aug-2023 ShareCast
Polarean Imaging gets first order for 'Xenoview' 26-Apr-2023 ShareCast
Polarean Imaging appoints director as strategic ... 17-Apr-2023 ShareCast
Polarean receives FDA approval for drug device c... 28-Dec-2022 ShareCast
Polarean inks long Covid research deal with Oxfo... 11-May-2022 ShareCast
Polarean Imaging receives research order from lo... 25-Apr-2022 ShareCast
FDA accepts Polarean's medical imaging drug-devi... 20-Apr-2022 ShareCast
Polarean installs xenon polariser system at Vanc... 11-Oct-2021 ShareCast
Polarean Imaging upbeat on progress as losses wi... 04-Jun-2021 ShareCast
Polarean Imaging gets another research unit order 10-May-2021 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

POLX Market Data

Currency UK Pounds
Share Price 0.000p
Closing Price Change 0.000p
% Change 0.00 %
52 Week High 0.000p
52 Week Low 0.000p
Volume 0
Shares Issued 1,207.03m

POLX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
Market averageMarket averageMarket averageMarket averageMarket average
21.21% above the sector average21.21% above the sector average21.21% above the sector average21.21% above the sector average21.21% above the sector average
Price Trend
Market averageMarket averageMarket averageMarket averageMarket average
54.29% below the sector average54.29% below the sector average54.29% below the sector average54.29% below the sector average54.29% below the sector average
Income Not Available
Growth
Market averageMarket averageMarket averageMarket averageMarket average
71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average71.43% above the sector average

POLX Dividends

No dividends found

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

POLX Key Personnel

CFO Charles Osborne
CEO Christopher von Jako

Top of Page